deferasirox has been researched along with Adult Fanconi Syndrome in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 15 (83.33) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Brook, R; Fraser, J; He, T; Lewis, D | 1 |
| Geara, A; Sayani, F; Yui, JC | 1 |
| Powell, JL; Shah, L; Zaritsky, JJ | 1 |
| Hall, AM; Unwin, RJ | 1 |
| Chan, MR; Elramah, M; Murphy, N; Vats, H; Zhong, W | 1 |
| Chan, GC; Cheuk, DK; Chiang, AK; Dee, CM; Ha, SY | 1 |
| Chuang, GT; Lu, MY; Tsai, IJ; Tsau, YK | 1 |
| Arora, S; Athale, UH; Bhatt, MD; Kirby-Allen, M; Papneja, K; Wiernikowski, JT | 1 |
| Arnon, R; Chu, J; Ramaswami, A; Rosen, DJ; Wistinghausen, B | 1 |
| Delarue, R; Fakhouri, F; Le Quintrec, M; Rafat, C; Ribeil, JA | 1 |
| Becker-Cohen, R; Even-Or, E; Miskin, H | 1 |
| Hider, RC | 1 |
| Bertrand, DM; Eas, F; Godin, M; Grangé, S; Guerrot, D | 1 |
| Baum, M | 1 |
| Barzilai-Birenbaum, S; Krause, I; Pazgal, I; Stark, P; Tamary, H; Yacobovich, J; Yaniv, I | 1 |
| Cheng, CH; Lo, FS; Wei, HY; Yang, CP | 1 |
| Bechtel, H; Kashtan, CE; Neglia, JP; Rheault, MN | 1 |
| Cho, EJ; Chueh, HW; Kim, JY; Koo, HH; Lee, SH; Sung, KW; Yoo, KH | 1 |
3 review(s) available for deferasirox and Adult Fanconi Syndrome
| Article | Year |
|---|---|
Deferasirox-associated Fanconi syndrome in adult patients with transfusional iron overload.
Topics: Adult; Benzoates; Deferasirox; Fanconi Syndrome; Humans; Iron Chelating Agents; Iron Overload; Triazoles | 2021 |
A case report of deferasirox-induced kidney injury and Fanconi syndrome.
Topics: Benzoates; Deferasirox; Fanconi Syndrome; Humans; Iron Chelating Agents; Iron Overload; Male; Renal Insufficiency; Triazoles; Young Adult | 2013 |
Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis.
Topics: Adolescent; Adult; Aged; Anemia, Diamond-Blackfan; Benzoates; Blood Transfusion; Child; Deferasirox; Electrolytes; Fanconi Syndrome; Female; Humans; Iron Chelating Agents; Iron Overload; Male; Transfusion Reaction; Triazoles | 2016 |
1 trial(s) available for deferasirox and Adult Fanconi Syndrome
| Article | Year |
|---|---|
Iron chelation treatment with deferasirox prior to high-dose chemotherapy and autologous stem cell transplantation may reduce the risk of hepatic veno-occlusive disease in children with high-risk solid tumors.
Topics: Acute Kidney Injury; Benzoates; Brain Neoplasms; Child; Child, Preschool; Deferasirox; Erythrocyte Transfusion; Fanconi Syndrome; Female; Ferritins; Hepatic Veno-Occlusive Disease; Humans; Induction Chemotherapy; Infant; Iron Chelating Agents; Male; Neuroblastoma; Stem Cell Transplantation; Transplantation, Autologous; Triazoles | 2012 |
14 other study(ies) available for deferasirox and Adult Fanconi Syndrome
| Article | Year |
|---|---|
Deferasirox-induced liver injury and Fanconi syndrome in a beta-thalassemia major male.
Topics: Adult; beta-Thalassemia; Chemical and Drug Induced Liver Injury, Chronic; Deferasirox; Fanconi Syndrome; Humans; Iron Chelating Agents; Male | 2020 |
A case of Fanconi syndrome due to a deferasirox overdose and a trial of plasmapheresis.
Topics: Benzoates; Deferasirox; Drug Overdose; Fanconi Syndrome; Half-Life; Humans; Iron Chelating Agents; Male; Plasmapheresis; Triazoles; Young Adult | 2017 |
A Case of Drug-Induced Proximal Tubular Dysfunction.
Topics: Deferasirox; Fanconi Syndrome; Humans; Iron Chelating Agents; Male; Young Adult | 2019 |
Incidence of deferasirox-associated renal tubular dysfunction in children and young adults with beta-thalassaemia.
Topics: Adolescent; Alkalosis; Benzoates; beta 2-Microglobulin; beta-Thalassemia; Chelation Therapy; Child; Child, Preschool; Deferasirox; Deferiprone; Deferoxamine; Fanconi Syndrome; Female; Humans; Iron Chelating Agents; Kidney Diseases; Kidney Tubules; Male; Pyridones; Retrospective Studies; Transfusion Reaction; Triazoles; Water-Electrolyte Imbalance; Young Adult | 2014 |
Transfusion-dependent thalassaemic patients with renal Fanconi syndrome due to deferasirox use.
Topics: Acidosis, Renal Tubular; Adolescent; Benzoates; Blood Transfusion; Child; Child, Preschool; Deferasirox; Fanconi Syndrome; Female; Hospitals, University; Humans; Hypophosphatemia; Incidence; Iron Chelating Agents; Male; Retrospective Studies; Risk Factors; Taiwan; Thalassemia; Triazoles; Young Adult | 2015 |
Fulminant Liver Failure in a Child With β-Thalassemia on Deferasirox: A Case Report.
Topics: Benzoates; beta-Thalassemia; Child, Preschool; Deferasirox; Fanconi Syndrome; Female; Humans; Liver Failure, Acute; Triazoles | 2017 |
Fanconi syndrome due to deferasirox.
Topics: Aged; Benzoates; Deferasirox; Fanconi Syndrome; Humans; Iron Chelating Agents; Male; Triazoles | 2009 |
Deferasirox treatment may be associated with reversible renal Fanconi syndrome.
Topics: Adolescent; Benzoates; Child; Deferasirox; Fanconi Syndrome; Female; Humans; Iron Chelating Agents; Iron Overload; Kidney; Male; Transfusion Reaction; Triazoles | 2010 |
Charge states of deferasirox-ferric iron complexes.
Topics: Benzoates; Deferasirox; Electrophysiological Phenomena; Fanconi Syndrome; Ferric Compounds; Humans; Iron Chelating Agents; Triazoles | 2010 |
Acute renal failure and Fanconi syndrome due to deferasirox.
Topics: Acute Kidney Injury; Aged; Benzoates; Chronic Disease; Deferasirox; Fanconi Syndrome; Humans; Iron Chelating Agents; Iron Overload; Kidney; Male; Triazoles | 2010 |
Renal Fanconi syndrome secondary to deferasirox: where there is smoke there is fire.
Topics: Benzoates; Deferasirox; Fanconi Syndrome; Humans; Iron Chelating Agents; Kidney Tubules, Proximal; Triazoles | 2010 |
Acquired proximal renal tubular dysfunction in β-thalassemia patients treated with deferasirox.
Topics: Adult; Benzoates; beta-Thalassemia; Blood Transfusion; Child; Combined Modality Therapy; Deferasirox; Fanconi Syndrome; Female; Humans; Iron Chelating Agents; Kidney Tubules, Proximal; Male; Triazoles; Water-Electrolyte Imbalance | 2010 |
Fanconi syndrome in a patient with β-thalassemia major after using deferasirox for 27 months.
Topics: Adolescent; Benzoates; beta-Thalassemia; Deferasirox; Fanconi Syndrome; Hospitalization; Humans; Iron Chelating Agents; Iron Overload; Kidney; Male; Transfusion Reaction; Triazoles | 2011 |
Reversible Fanconi syndrome in a pediatric patient on deferasirox.
Topics: Benzoates; beta-Thalassemia; Child; Deferasirox; Erythrocyte Transfusion; Fanconi Syndrome; Female; Humans; Iron Chelating Agents; Iron Overload; Male; Triazoles | 2011 |